Normal tissue tolerance to external beam radiation therapy: Larynx and pharynx;Dose de tolérance à l'irradiation des tissus sains: larynx et pharynx

Cancer/Radiotherapie

Volumn 14, Issue 4-5, 2010, Pages 301-306

  Debelleix, C ^a,b   Pointreau, Y ^c,d,e,f   Lafond, C ^g   Denis, F ^g   Calais, G ^c,d   Bourhis, J H ^h  

^a Dax Côte d'Argent Hospital   (France)

^b HÔPITAL SAINT ANDRÉ   (France)

^c CHU BRETONNEAU   (France)

^d UNIVERSITÉ DE TOURS   (France)

^e CNRS   (France)

^f UNIVERSITY HOSPITAL OF TOURS   (France)

^g CENTRE JEAN BERNARD   (France)

^h INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Ionizing radiation; Larynx; Organ at risk; Pharynx; Tolerability

Indexed keywords

ARTICLE; EXTERNAL BEAM RADIOTHERAPY; HEAD AND NECK CANCER; HUMAN; IONIZING RADIATION; LARYNX; LARYNX EDEMA; NASOPHARYNX; OROPHARYNX; PHARYNX; PRIORITY JOURNAL; RADIATION DOSE;

EID: 77955329652     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2010.05.002     Document Type: Article

References (37)

1. Agarwal J.P., Baccher G.K., Waghmare C.M., Mallick I., Ghosh-Laskar S., Budrukkar A., et al. Factors affecting the quality of voice in the early glottic cancer treated with radiotherapy. Radiother Oncol 2009, 90:177-182.
2. Bjordal K., Hammerlid E., Ahlner-Elmqvist M., de Graeff A., Boysen M., Evensen J.F., et al. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol 1999, 17:1008-1019.
3. Brandenburg J.H. Laser cordotomy versus radiotherapy: an objective cost analysis. Ann Otol Rhinol Laryngol 2001, 110:312-318.
4. Caglar H.B., Allen A.M., Othus M., Li Y., Burke E., Wirth L., et al. Dose to the larynx predicts for swallowing complications following IMRT and chemotherapy. Int J Radiat Oncol Biol Phys 2007, 69:S53-S54.
5. Chen A.Y., Frankowski R., Bishop-Leone J., Hebert T., Leyk S., Lewin J., et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the MD. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 2001, 127:870-876.
6. Debelleix C.P.Y., Chapet S., Sire C., Tuchais S., Faivre S., Alphonsi M., et al. Évaluation à long terme de la voix et déglutition dans le cadre de l'essai de phase III randomisé de préservation laryngée GORTEC 2000-01. Cancer Radiother 2009, 13:680. [abstract].
7. Doornaert P. The mean radiation dose in pharyngheal structures is a strong predictor of acute and persistent swallowing dysfunction and quality of life in head and neck radiotherapy. Int J Radiat Oncol Biol Phys 2007, 69:54.
8. Dornfeld K., Simmons J.R., Karnell L., Karnell M., Funk G., Yao M., et al. Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet- and speech-related quality of life. Int J Radiat Oncol Biol Phys 2007, 68:750-757.
9. Eisbruch A., Schwartz M., Rasch C., Vineberg K., Damen E., Van As C.J., et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys 2004, 60:1425-1439.
10. Emami B., Lyman J., Brown A., Coia L., Goitein M., Munzenrider J.E., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21:109-122.
11. Feng F.Y., Kim H.M., Lyden T.H., Haxer M.J., Feng M., Worden F.P., et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 2007, 68:1289-1298.
12. Forastière A.A., Goepfert H., Maor M., Pajak T.F., Weber R., Morrison W., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003, 349:2091-2098.
13. Fung K., Yoo J., Leeper H.A., Hawkins S., Heeneman H., Doyle P.C., et al. Vocal function following radiation for non-laryngeal versus laryngeal tumors of the head and neck. Laryngoscope 2001, 111:1920-1924.
14. Hans S, Vaissière J, Brasnu D. Quels paramètres peut-on mesurer pour évaluer un modèle de voix pathologique. XXIIIèmes Journées d'Etudes sur la Parole, Société Française d'Acoustique, 2000;413-16.
15. Henk J.M. Controlled trials of synchronous chemotherapy with radiotherapy in head and neck cancer: overview of radiation morbidity. Clin Oncol (R Coll Radiol) 1997, 9:308-312.
16. Hirano Clinical examination of voice (disorders of human communication) 1981, Springer-Verlag, New York, p. 81-4.
17. Hogikyan N.D., Sethuraman G. Validation of an instrument to measure voice-related quality of life (V-RQOL). J Voice 1999, 13:557-569.
18. Jacobson B.H., Johnson A., Grywalski C., Silbergleit A., Jacobson G., Benninger M.S., et al. The voice handicap index (VHI): development and validation. Am J Speech Lang Pathol 1997, 6:66.
19. Jensen K., Lambertsen K., Grau C. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation with dose and volume parameters. Radiother Oncol 2007, 85:74-82.
20. Kulik C., Mazurier J., Lartigau É. Probabilités de contrôle tumoral et de complications (TCP/NTCP) après radiothérapie: aspects méthodologiques, physiques et biologiques (Radiotherapy). Cancer Radiother 2002, 6:155s-165s.
21. Lefebvre J.L., Ang K.K. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary. Int J Radiat Oncol Biol Phys 2009, 73:1293-1303.
22. Levendag P.C., Teguh D.N., Voet P., van der Est H., Noever I., de Kruijf W.J., et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. Radiother Oncol 2007, 85:64-73.
23. Machtay M., Moughan J., Trotti A., Garden A.S., Weber R.S., Cooper J.S., et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008, 26:3582.
24. Mazeron J.J., Grimard L. Effets tardifs des radiations ionisantes sur les tissus de la sphère otorhinolaryngologique. Cancer Radiother 1997, 1:692-705.
25. Núñez Batalla F., Caminero Cueva M.J., Señaris González B., Llorente Pendás J.L., Gorriz Gil C., López Llames A., et al. Voice quality after endoscopic laser surgery and radiotherapy for early glottic cancer: objective measurements emphasizing the Voice Handicap Index. Eur Arch Otorhinolaryngol 2008, 265:543-548.
26. O'Meara E.A., Machtay M., Moughan J., McIlvaine J., Galvin J.M., Forastiere A., et al. Associations between radiation doses to pharyngeal regions and severe late toxicity in head and neck cancer patients treated with concurrent chemoradiotherapy-An RTOG analysis. Int J Radiation Oncol Biol Phys 2007, 69:S54-S55.
27. Pointreau Y., Garaud P., Chapet S., Sire C., Tuchais C., Tortochaux J., et al. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 2009, 101:498-506.
28. Popovtzer A., Cao Y., Feng F.Y., Eisbruch A. Anatomical changes in the pharyngeal constrictors after chemo-irradiation of head and neck cancer and their dose-effect relationships: MRI-based study. Radiother Oncol 2009, 93:510-515.
29. Rancati T., Fiorino C., Sanguineti G. NTCP modeling of subacute/late laryngeal edema scored by fiberoptic examination. Int J Radiat Oncol Biol Phys 2009, 75:915-923.
30. Rancati T., Schwarz M., Allen A.M., Feng F., Popovtzer A., Mittal B., et al. Radiation dose-volume effects in the larynx and pharynx. Int J Radiat Oncol Biol Phys 2010, 76:S64-S69.
31. Roh J.L., Kim A.Y., Cho M.J. Xerostomia following radiotherapy of the head and neck affects vocal function. J Clin Oncol 2005, 23:3016-3023.
32. Rosier J.F., Grégoire V., Counoy H., Octave-Prignot M., Rombaut P., Scalliet P., et al. Comparison of external radiotherapy, laser microsurgery and partial laryngectomy for the treatment of T1N0M0 glottic carcinomas: a retrospective evaluation. Radiother Oncol 1998, 48:175-183.
33. Sanguineti G., Adapala P., Endres E.J., Brack C., Fiorino C., Sormani M.P., et al. Dosimetric predictors of laryngeal edema. Int J Radiat Oncol Biol Phys 2007, 68:741-749.
34. Guide des procédures de radiothérapie externe 2007. Cancer Radiother 2008, 12:143-313. Société française de radiothérapie oncologique.
35. Trotti A., Colevas A.D., Setser A., Rusch V., Jaques D., Budach V., et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003, 13:176-181.
36. Verdonck-De Leeuw I.M., Hilgers F.J.M., Keus R.B., Koopmans-Van Beinum F.J., Greven A.J., De Jong J.M.A., et al. Multidimensional assessment of voice characteristics after radiotherapy for early glottic cancer. Laryngoscope 1999, 109:241-248.
37. Woisard V., Bodin S., Puech M. The Voice Handicap Index: impact of the translation in French on the validation. Rev Laryngol Otol Rhinol (Bord) 2004, 125:307.